Table 8.
Response | Respondents’ site of practice, N (%) | |
---|---|---|
Community | Hospital | |
Nature of research conducted | N = 35 | N = 36 |
Data collection on patients’ previous medications | 11 (31.4) | 15 (41.7) |
Data collection using questionnaire | 7 (20.0) | 13 (36.1) |
Evaluation of self-medication issues in the practice setting | 8 (22.9) | 4 (11.1) |
Research on use and misuse of antibiotics | 6 (17.1) | 1 (2.8) |
Adverse drug reaction profile | NM (0.0) | 1 (2.8) |
Radiopharmaceutical research among cancer patients | NM (0.0) | 1 (2.8) |
Information system | NM (0.0) | 1 (2.8) |
Use of antimalarial and contraceptives | 1 (2.9) | NM (0.0) |
Customer services | 1 (2.9) | NM (0.0) |
Pharmacy management | 1 (2.9) | NM (0.0) |
Utilisation of data generated from the research conducted was | N = 30 | N = 28 |
Analysed and written up for publication | 1(3.3) | 12 (42.9) |
Use only to guide routine practice | 12 (40.0) | 6 (21.4) |
Use to identify gaps to focus on for improve pharmacy practice | 11(36.7) | 5 (17.9) |
Not process, but research only done for satisfaction or documentation | 6 (20.0) | 4 (14.3) |
Use for postgraduate work | NM (0.0 | 1 (3.5) |
Suggestions on measures to stimulate interest in pharmacy practice research | N = 137 | N = 108 |
Assurance that research results will be implemented in practice | 72 (52.6) | 53 (49.1) |
Reimbursement for conducting research in pharmacy practice | 60 (43.8) | 38 (35.2) |
Improved/integrated interaction between pharmacist and other healthcare team | 3 (2.2) | NM |
Creating awareness about pharmacy practice-based research and benefit to practice | 2 (1.5) | NM |
Recognition by other members of healthcare team | NM | 17 (15.7) |
N = number and is based on respondents who had previously participated in research